A Single-Center Phase 2 Open-Label Trial Evaluating the Safety and Efficacy of Daratumumab in Treatment of Patients with Monoclonal Gammopathy of Renal Significance

被引：0
|
作者：
Zand, Ladan
Rajkumar, S. Vincent
Sethi, Sanjeev
Leung, Nelson
Fervenza, Fernando C.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of Ninjin’yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
    Taro Yagi
    Kenjiro Sawada
    Mayuko Miyamoto
    Yasuto Kinose
    Satoshi Nakagawa
    Tsuyoshi Takiuchi
    Michiko Kodama
    Eiji Kobayashi
    Kae Hashimoto
    Seiji Mabuchi
    Takuji Tomimatsu
    Kiyoshi Yoshino
    Tadashi Kimura
    BMC Women's Health, 22
  • [42] Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trial
    Ulys, Albertas
    Jankevicus, Feliksas
    Jievaltas, Mindaugas
    Venckus, Raimundas
    Auskalnis, Stasys
    Kardelis, Zygimantas
    Barisiene, Marija
    Maclean, Carol M.
    van Os, Steve
    Larsen, Finn
    PROSTATE, 2024, 84 (06): : 584 - 598
  • [43] Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial
    Yagi, Taro
    Sawada, Kenjiro
    Miyamoto, Mayuko
    Kinose, Yasuto
    Nakagawa, Satoshi
    Takiuchi, Tsuyoshi
    Kodama, Michiko
    Kobayashi, Eiji
    Hashimoto, Kae
    Mabuchi, Seiji
    Tomimatsu, Takuji
    Yoshino, Kiyoshi
    Kimura, Tadashi
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [44] Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol
    Solanich, X.
    Antoli, A.
    Padulles, N.
    Fanlo-Maresma, M.
    Iriarte, A.
    Mitjavila, F.
    Capdevila, O.
    Molina, M.
    Sabater, J.
    Bas, J.
    Mensa-Vilaro, A.
    Niubo, J.
    Calvo, N.
    Bolivar, S.
    Rigo-Bonnin, R.
    Arregui, L.
    Tebe, C.
    Hereu, P.
    Videla, S.
    Corbella, X.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 21
  • [45] A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS
    Bagley, Stephen
    Nasrallah, MacLean
    O'Rourke, Donald
    Hussain, Jasmin
    Maloney-Wilensky, Eileen
    Prior, Timothy
    Brem, Steven
    Desai, Arati
    NEURO-ONCOLOGY, 2019, 21 : 219 - 219
  • [46] The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial
    Miyazaki, Taiga
    Nakamura, Shigeki
    Hashiguchi, Kohji
    Kobayashi, Tsutomu
    Fukushima, Kiyoyasu
    Fukuda, Yuichi
    Kondo, Akira
    Inoue, Yuichi
    Koga, Hironobu
    Sasaki, Eisuke
    Nagayoshi, Yosuke
    Higashiyama, Yasuhito
    Yoshida, Masataka
    Takazono, Takahiro
    Saijo, Tomomi
    Morinaga, Yoshitomo
    Yamamoto, Kazuko
    Imamura, Yoshifumi
    Mikushi, Shinya
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Kohno, Shigeru
    Mukae, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (11) : 886 - 893
  • [47] Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
    Kresch, Eliyahu
    Lima, Thiago Fernandes Negris
    Molina, Manuel
    Deebel, Nicholas A.
    Reddy, Rohit
    Patel, Mehul
    Loloi, Justin
    Carto, Chase
    Nackeeran, Sirpi
    Gonzalez, Daniel C.
    Ory, Jesse
    Ramasamy, Ranjith
    SEXUAL MEDICINE, 2023, 11 (02)
  • [48] Garadacimab for hereditary angioedema prophylaxis: Efficacy and safety from a Phase 2 open-label extension trial
    Craig, T. J.
    Reshef, A.
    Lumry, W. R.
    Saguer, I. Martinez
    Jacobs, J. S.
    Yang, W. H.
    Aygoren-Pursun, E.
    Keith, P. K.
    Busse, P.
    Magerl, M.
    Feuersenger, H.
    Bica, M. A.
    Glassman, F.
    Pragst, I.
    Levy, D. S.
    ALLERGOLOGIE, 2023, 46 (08) : 560 - 561
  • [49] Evaluating the efficacy of cabozantinib in patients with advanced renal cell carcinoma with bone metastasis: An open-label phase 2 study.
    Hongo, Fumiya
    Nakai, Yasutomo
    Nozawa, Masahiro
    Kato, Taigo
    Kamikawa, Sadanori
    Tamada, Satoshi
    Yamada, Kaori
    Soeda, Junpei
    Tsubouchi, Ryoichi
    Osaka, Tsuyoshi
    Uemura, Hirotsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 535 - 535
  • [50] A SINGLE-CENTER, OPEN-LABEL STUDY OF 1726 NM LASER FOR TREATMENT OF ACNE VULGARIS
    Bhatia, Ashish C.
    Kothare, Amogh
    LASERS IN SURGERY AND MEDICINE, 2022, 54 : S110 - S110
12345